Health Care Deal News- April 30, 2012


Brought to you by

April 30, 2012 Issue:


  1. Recent Health Care M&A Deals 
  2. Spotlight on: Pharmaceuticals
  3. Spotlight on: Medical Devices
  4. Conference Calendar


Recent Health Care M&A Deals





AstraZeneca plc

Ardea Biosciences, Inc.

$1.26 billion





BioTime, Inc.

ZenneX, Inc.

$6.3 million

Water Street Healthcare Partners

Sports medicine business (Orthofix International NV)

$157.5 million






Mustafa Nevzat Pharmaceuticals

$700.0 million


Get Two Reports for the Price of One ($595 savings)- Offer Extended to 4/30!
Deals have been made. The 2012 Health Care Services Acquisition Report contains knowledge that is crucial to the success of your business, your investments, and your clients. Take advantage of our limited-time 2 for 1 offer—Extended to orders placed through April 30! Buy our 2012 Health Care Services Acquisition Report and receive The 2011 Health Care Services Acquisition Report free! Now that’s a recession resistant deal. Place your order by 4/30 by calling 1-800-248-1668 or order online at


Spotlight on: Pharmaceuticals
GlaxoSmithKline continues the sell-off of its generic drugs. In March, it announced selling a portfolio of European over-the-counter drugs to Belgium’s Omega Pharma for approximately $612.0 million. The portfolio includes Solpadeine (pain), Zantac (stomach acid) and Beconase (hay fever), as well as vitamin and feminine hygiene lines. Included in the deal is a manufacturing site in Herrenberg, Germany........Read more 


Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.


Spotlight on: Medical Devices
In March’s largest deal in any sector of health care, Boston Scientific (NYSE: BSX) is offering to acquire Cameron Health for as much as $1.35 billion. Based in San Clemente, California, Cameron’s S-ICD wireless system is the only commercially available subcutaneous implantable defibrillator. This defibrillator does not touch the heart and blood vessels and so may offer competitive advantages over conventional defibrillators....Read more

Conference Calendar...Click here to see more